Mehmet Yuksekkaya

Dr. Mehmet Yuksekkaya

Biomedical Engineering, Ankara University, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2016 in Small
Verified
Journal Article
Closed access
PDF file
SSSu Ryon Shin
Su Ryon Shin
CZClaudio Zihlmann
Claudio Zihlmann
Mohsen AkbariMohsen Akbari
Mohsen Akbari
PAPribpandao Assawes
Pribpandao Assawes
LCLouis Cheung
Louis Cheung
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

6 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHadi Shafiee
Hadi Shafiee
WAWaseem Asghar
Waseem Asghar
Fatih InciFatih Inci
Fatih Inci
Mehmet YuksekkayaMehmet Yuksekkaya
Mehmet Yuksekkaya
MJMuntasir Jahangir
Muntasir Jahangir
UDUtkan Demirci
Utkan Demirci
The need for sensitive, robust, portable and inexpensive biosensing platforms is of significant interest in clinical applications for disease diagnosis and treatment monitoring at the point-of-care (POC) settings. Rapid, accurate POC diagnostic assays play a crucial role in developing countries, where there are limited laboratory infrastructure, trained personnel and financial support. However, current diagnostic assays commonly require long assay time, sophisticated infrastructure and expensive reagents that are not compatible with resource-constrained settings. Although paper and flexible material-based platform technologies provide alternative approaches to develop POC diagnostic assays for broad applications in medicine, they have technical challenges integrating to different detection modalities. Here, we address the limited capability of current paper and flexible material-based platforms by integrating cellulose paper and flexible polyester films as diagnostic biosensing materials with various detection modalities through the development and validation of new widely applicable electrical and optical sensing mechanisms using antibodies and peptides. By incorporating these different detection modalities, we present selective and accurate capture and detection of multiple biotargets including viruses (Human Immunodeficieny Virus-1), bacteria (Escherichia coli and Staphylococcus aureus) and cells (CD4+ T lymphocytes) from fingerprick volume equivalent of multiple biological specimens such as whole blood, plasma and peritoneal dialysis effluent with clinically relevant detection and sensitivity.

23 October 2015 in Light: Science & Applications
Verified
Journal Article
Open access
PDF file
ASAntonio Carlos Sobieranski
Antonio Carlos Sobieranski
Fatih InciFatih Inci
Fatih Inci
HTH Cumhur Tekin
H Cumhur Tekin
Mehmet YuksekkayaMehmet Yuksekkaya
Mehmet Yuksekkaya
ECEros Comunello
Eros Comunello
UDUtkan Demirci
Utkan Demirci
In this paper, an irregular displacement-based lensless wide-field microscopy imaging platform is presented by combining digital in-line holography and computational pixel super-resolution using multi-frame processing. The samples are illuminated by a nearly coherent illumination system, where the hologram shadows are projected into a complementary metal-oxide semiconductor-based imaging sensor. To increase the resolution, a multi-frame pixel resolution approach is employed to produce a single holographic image from multiple frame observations of the scene, with small planar displacements. Displacements are resolved by a hybrid approach: (i) alignment of the LR images by a fast feature-based registration method, and (ii) fine adjustment of the sub-pixel information using a continuous optimization approach designed to find the global optimum solution. Numerical method for phase-retrieval is applied to decode the signal and reconstruct the morphological details of the analyzed sample. The presented approach was evaluated with various biological samples including sperm and platelets, whose dimensions are in the order of a few microns. The obtained results demonstrate a spatial resolution of 1.55 μm on a field-of-view of ≈30 mm2.

17 February 2016 in Scientific Reports
Verified
Journal Article
Open access
WAWaseem Asghar
Waseem Asghar
Mehmet YuksekkayaMehmet Yuksekkaya
Mehmet Yuksekkaya
HSHadi Shafiee
Hadi Shafiee
MZMichael Zhang
Michael Zhang
MOMehmet O Ozen
Mehmet O Ozen
UDUtkan Demirci
Utkan Demirci
Although materials and engineered surfaces are broadly utilized in creating assays and devices with wide applications in diagnostics, preservation of these immuno-functionalized surfaces on microfluidic devices remains a significant challenge to create reliable repeatable assays that would facilitate patient care in resource-constrained settings at the point-of-care (POC), where reliable electricity and refrigeration are lacking. To address this challenge, we present an innovative approach to stabilize surfaces on-chip with multiple layers of immunochemistry. The functionality of microfluidic devices using the presented method is evaluated at room temperature for up to 6-month shelf life. We integrated the preserved microfluidic devices with a lensless complementary metal oxide semiconductor (CMOS) imaging platform to count CD4+T cells from a drop of unprocessed whole blood targeting applications at the POC such as HIV management and monitoring. The developed immunochemistry stabilization method can potentially be applied broadly to other diagnostic immuno-assays such as viral load measurements, chemotherapy monitoring and biomarker detection for cancer patients at the POC.

15 June 2018 in Advanced Science
Verified
Journal Article
Open access
PDF file
FIFatih Inci
Fatih Inci
MOMehmet O Ozen
Mehmet O Ozen
Yeseren SaylanYeseren Saylan
Yeseren Saylan
MMMorteza Miansari
Morteza Miansari
DCDuygu Cimen
Duygu Cimen
UDUtkan Demirci
Utkan Demirci
One out of every six American women has been the victim of a sexual assault in their lifetime. However, the DNA casework backlog continues to increase outpacing the nation's capacity since DNA evidence processing in sexual assault casework remains a bottleneck due to laborious and time‐consuming differential extraction of victim's and perpetrator's cells. Additionally, a significant amount (60–90%) of male DNA evidence may be lost with existing procedures. Here, a microfluidic method is developed that selectively captures sperm using a unique oligosaccharide sequence (Sialyl‐LewisX), a major carbohydrate ligand for sperm‐egg binding. This method is validated with forensic mock samples dating back to 2003, resulting in 70–92% sperm capture efficiency and a 60–92% reduction in epithelial fraction. Captured sperm are then lysed on‐chip and sperm DNA is isolated. This method reduces assay‐time from 8 h to 80 min, providing an inexpensive alternative to current differential extraction techniques, accelerating identification of suspects and advancing public safety.

5 June 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHadi Shafiee
Hadi Shafiee
MKManoj Kumar Kanakasabapathy
Manoj Kumar Kanakasabapathy
FJFranceline Juillard
Franceline Juillard
MKMert Keser
Mert Keser
MSMagesh Sadasivam
Magesh Sadasivam
UDUtkan Demirci
Utkan Demirci
We report a biosensing platform for viral load measurement through electrical sensing of viruses on a flexible plastic microchip with printed electrodes. Point-of-care (POC) viral load measurement is of paramount importance with significant impact on a broad range of applications, including infectious disease diagnostics and treatment monitoring specifically in resource-constrained settings. Here, we present a broadly applicable and inexpensive biosensing technology for accurate quantification of bioagents, including viruses in biological samples, such as plasma and artificial saliva, at clinically relevant concentrations. Our microchip fabrication is simple and mass-producible as we print microelectrodes on flexible plastic substrates using conductive inks. We evaluated the microchip technology by detecting and quantifying multiple Human Immunodeficiency Virus (HIV) subtypes (A, B, C, D, E, G, and panel), Epstein-Barr Virus (EBV), and Kaposi’s Sarcoma-associated Herpes Virus (KSHV) in a fingerprick volume (50 µL) of PBS, plasma, and artificial saliva samples for a broad range of virus concentrations between 102 copies/mL and 107 copies/mL. We have also evaluated the microchip platform with discarded, de-identified HIV-infected patient samples by comparing our microchip viral load measurement results with reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) as the gold standard method using Bland-Altman Analysis.